<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000045029">
  <TermName>atrasentan</TermName>
  <TermPronunciation>(A-truh-SEN-tan)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called endothelin-1 protein receptor antagonists.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000728247" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;atrasentan&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000728246" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;atrasentan&quot;" language="es" id="_4"/>
  <SpanishTermName>atrasentán</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento de cáncer. Es un tipo de antagonista del receptor de la proteína endotelina-1.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateLastModified>2003-10-15</DateLastModified>
</GlossaryTerm>
